SGLT2 inhibitor empagliflozin can be used to treat insulin resistance in the brain, finds study

By | December 21, 2021
Overweight or obesity, an unfavorable distribution of fat in the body and the development of type 2 diabetes are often associated with a reduced effect of the hormone insulin in many organs, including the brain (insulin resistance).